VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DCBO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DCBODocebo Inc.
$18.44$530M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. DCBO
  4. Financial Ratios

Docebo Inc. (DCBO) Financial Ratios

Latest Ratios: P/E Ratio 14.2x · EV/EBITDA 16.4x · ROE 58.0%. (2017–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

DCBO Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Market Cap$530M$652M$1.4B$1.6B$1.1B$2.2B$1.9B———
Enterprise Value$461M$583M$1.3B$1.6B$915M$2.0B$1.7B———
P/E Ratio →14.1817.0852.06573.90165.70—————
P/S Ratio2.152.646.399.017.8921.2429.93———
P/B Ratio7.328.8223.9832.125.8711.619.40———
P/FCF18.2322.4149.47106.29934.67—507.64———
P/OCF17.6221.6647.36102.07493.07—393.10———

P/E links to full P/E history page with 30-year chart

DCBO EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
EV / Revenue—2.365.978.626.4019.2126.50———
EV / EBITDA16.3820.7052.45—140.37—————
EV / EBIT18.5122.8354.16303.29112.15—————
EV / FCF—20.0246.22101.74758.01—449.47———

DCBO Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Gross Margin79.0%79.0%81.0%80.9%80.3%80.1%81.7%79.8%79.1%74.6%
Operating Margin10.1%10.1%9.8%-2.1%2.9%-12.9%-12.1%-23.7%-33.1%-40.2%
Net Profit Margin15.5%15.5%12.3%1.6%4.9%-13.0%-12.7%-28.7%-41.6%-42.7%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
ROE58.0%58.0%49.3%2.3%3.7%-7.0%-6.9%-163.1%——
ROA19.2%19.2%15.3%1.3%2.5%-5.2%-5.0%-30.9%-98.9%-77.0%
ROIC411.0%411.0%————————
ROCE34.4%34.4%35.5%-2.9%2.1%-6.6%-6.2%-82.7%——

DCBO Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Debt / Equity0.060.060.030.040.020.020.020.11——
Debt / EBITDA0.160.160.06—0.47—————
Net Debt / Equity—-0.94-1.58-1.38-1.11-1.11-1.08-1.36——
Net Debt / EBITDA-2.47-2.47-3.69—-32.71—————
Debt / FCF—-2.39-3.25-4.56-176.66—-58.18———
Interest Coverage39.4439.44107.2817.2929.29-30.42-15.40-12.96—-46.68

Net cash position: cash ($74M) exceeds total debt ($4M)

DCBO Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Current Ratio1.151.151.201.263.123.635.212.070.470.73
Quick Ratio1.151.151.201.263.123.635.212.070.470.73
Cash Ratio0.600.600.720.722.573.114.801.620.150.29
Asset Turnover—1.201.141.140.500.390.250.652.041.80
Inventory Turnover——————————
Days Sales Outstanding—82.7676.7386.2696.9697.2891.6089.8382.7593.95

DCBO Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Dividend Yield——————————
Payout Ratio——————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Earnings Yield7.0%5.9%1.9%0.2%0.6%—————
FCF Yield5.5%4.5%2.0%0.9%0.1%—0.2%———
Buyback Yield9.0%7.3%0.8%9.8%0.0%0.0%0.0%———
Total Shareholder Yield9.0%7.3%0.8%9.8%0.0%0.0%0.0%———
Shares Outstanding—$29M$31M$34M$34M$33M$29M$24M$30M$30M

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Enterprise Software Consolidation Headwinds

Premium Multiples Facing Growth Headwinds

As reported in recent financial statements, Docebo's forward P/E of 10.91 and P/S of 2.04 suggest that the market is pricing the company as a maturing software entity rather than a high-growth disruptor, reflecting a cautious outlook on its ability to sustain historical expansion rates.

The current valuation multiples appear to reflect a transition phase where investors are discounting the company's growth potential in favor of its newfound GAAP profitability. Given the deceleration in top-line growth, the current P/S ratio warrants investigation into whether the market is adequately pricing the risk of enterprise software consolidation.

Capital Efficiency Volatility Remains High

Based on the provided financial data, Docebo's ROIC has exhibited extreme volatility, swinging from a peak of 157.9% in 2025Q4 to a negative 0.2% in 2026Q1, which indicates that the company's ability to compound capital is currently inconsistent and highly sensitive to quarterly accounting adjustments.

The dramatic shift in ROIC suggests that the company's capital allocation strategy, particularly regarding recent share repurchases and debt issuance, is significantly impacting its return profile. Investors should monitor whether this volatility is a structural byproduct of the company's current capital structure or merely a temporary artifact of aggressive balance sheet management.

Working Capital Cycles Require Scrutiny

According to the latest quarterly filings, Docebo's DSO has remained relatively stable near 76 days, yet the significant DPO levels exceeding 200 days suggest that the company is heavily reliant on stretching supplier payments to manage its underlying cash conversion cycle and liquidity position.

The high DPO relative to DSO indicates that Docebo is effectively utilizing its vendor relationships as a source of interest-free financing. While this supports short-term cash flow, it may indicate limited leverage with suppliers or a strategic necessity to preserve cash for other operational priorities.

Liquidity Buffer Nearing Critical Thresholds

As evidenced by the reported figures, Docebo's current ratio has compressed to 0.79 in 2026Q1, down from 1.26 in 2023Q4, signaling a tightening liquidity position that may limit the company's flexibility to navigate unexpected operational downturns or fund future strategic initiatives without external financing.

The decline in the current ratio below parity suggests that the company's short-term assets are no longer sufficient to cover its immediate liabilities. This trend warrants close monitoring, as it may indicate that the company's aggressive capital allocation strategy is beginning to constrain its operational safety net.

Misapplication of P/E Multiples

Based on the company's business model, the P/E ratio is a frequently misapplied metric that obscures the true earning power of the firm by failing to account for the significant non-cash stock-based compensation expenses that distort GAAP net income figures.

Analysts should instead focus on free cash flow yield or EV/EBITDA, as these metrics better capture the underlying cash generation of the platform. Relying on P/E in this context may lead to an inaccurate assessment of the company's valuation, as it ignores the impact of non-operating items on the bottom line.

Download Financial Ratios Data

Includes 30+ ratios · 9 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

DCBO — Frequently Asked Questions

Quick answers to the most common questions about buying DCBO stock.

What is Docebo Inc.'s P/E ratio?

Docebo Inc.'s current P/E ratio is 14.2x. The historical average is 78.3x.

What is Docebo Inc.'s EV/EBITDA?

Docebo Inc.'s current EV/EBITDA is 16.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 36.6x.

What is Docebo Inc.'s ROE?

Docebo Inc.'s return on equity (ROE) is 58.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is -9.1%.

Is DCBO stock overvalued?

Based on historical data, Docebo Inc. is trading at a P/E of 14.2x. Compare with industry peers and growth rates for a complete picture.

What are Docebo Inc.'s profit margins?

Docebo Inc. has 79.0% gross margin and 10.1% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Docebo Inc. have?

Docebo Inc.'s Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.